Hemogenyx Pharmaceuticals PLC Announces Presentation at CBD ST Conference - StockTitan
| HOPHF Stock | USD 0 0.00 0.00% |
Roughly 56% of Hemogenyx Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Hemogenyx Pharmaceuticals Plc pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Hemogenyx Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Hemogenyx Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Hemogenyx Pharmaceuticals pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Hemogenyx daily returns and investor perception about the current price of Hemogenyx Pharmaceuticals Plc as well as its diversification or hedging effects on your existing portfolios.
Hemogenyx |
Hemogenyx Pharmaceuticals PLC Announces Presentation at CBD ST Conference StockTitan
Read at news.google.com
 |
Hemogenyx Pharmaceuticals Fundamental Analysis
We analyze Hemogenyx Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hemogenyx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hemogenyx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Hemogenyx Pharmaceuticals is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Hemogenyx Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hemogenyx Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Hemogenyx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Hemogenyx Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Hemogenyx Pharmaceuticals Related Equities
| SNTI | Senti Biosciences | 3.65 | ||||
| MNPR | Monopar Therapeutics | 1.24 | ||||
| GNLX | Genelux Common | 0.00 | ||||
| FHTX | Foghorn Therapeutics | 0.00 | ||||
| FENC | Fennec Pharmaceuticals | 0.33 | ||||
| CVKD | Cadrenal Therapeutics, | 0.71 | ||||
| INBX | Inhibrx | 0.79 | ||||
| CING | Cingulate | 1.15 | ||||
| ELYM | Eliem Therapeutics | 1.90 | ||||
| CELC | Celcuity LLC | 2.49 | ||||
| DYAI | Dyadic International | 3.03 | ||||
| PMN | ProMIS Neurosciences | 4.95 | ||||
| QNRX | Quoin Pharmaceuticals | 6.05 | ||||
| ELVN | Enliven Therapeutics | 8.43 | ||||
| CCCC | C4 Therapeutics | 8.92 | ||||
| GLUE | Monte Rosa | 9.52 | ||||
| PRLD | Prelude Therapeutics | 9.82 | ||||
| STTK | Shattuck Labs | 10.53 |
Complementary Tools for Hemogenyx Pink Sheet analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |